Regulatory News
Friday, December 2, 2016
BRIEF-GSK's lung drug gains approval in Japan
* Relvar Ellipta 100/25 mcg gains approval in Japan for use
in patients with COPD
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment